In light of the COVID-19 crisis, do you have the necessary Directors and Officers coverage?
With the addition of the global COVID-19 pandemic, an already tumultuous D&O insurance environment has the potential to get much worse.
The federally mandated ICD-10 conversion, with its looming implementation deadline of October 1, 2013, will likely exceed both HIPAA and Y2K in terms of cost and risk. Yet, the results of a recent Milliman study suggest that many healthcare organizations do not appear to have taken significant steps to prepare for implementation and do not view ICD-10 as offering opportunities to gain competitive advantages.
This white paper provides an overview of ICD-10, examines current industry perceptions and levels of readiness for the ICD-10 transition, discusses possible misconceptions reported by survey respondents, and provides information about possible transition strategies.